Alterations in the CTRB2 gene and response to chemotherapy in pancreatic cancer.

Saved in:
Bibliographic Details
Title: Alterations in the CTRB2 gene and response to chemotherapy in pancreatic cancer.
Authors: Jazieh K; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, United States of America., Carlson EE; Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, United States of America., Siddiqui Z; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States of America., Connelly KE; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Zhong J; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Hoskins JW; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Rabe KG; Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, United States of America., Oberg AL; Department of Quantitative Health Sciences, Computational Biology, Mayo Clinic, Rochester, Minnesota, United States of America., Sicotte H; Department of Quantitative Health Sciences, Computational Biology, Mayo Clinic, Rochester, Minnesota, United States of America., Carr RM; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, United States of America., Amundadottir LT; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Antwi SO; Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Jacksonville, Florida, United States of America.
Corporate Authors: MAYO-RGC Project Generation, Regeneron Genetics Center
Source: PloS one [PLoS One] 2026 Feb 19; Vol. 21 (2), pp. e0343022. Date of Electronic Publication: 2026 Feb 19 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0343022